Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (21-30 of 602) with videos related to

Pageof 61
Sort By:
Neuropharmacology|April 17, 2010
Biomarkers in translational research of Alzheimer's diseaseRawan Tarawneh, David M Holtzman
Nature Reviews. Immunology|August 25, 2018
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlightYang Shi, David M Holtzman
Trends in Immunology|September 15, 2024
New insights into innate immunity in Alzheimer's disease: from APOE protective variants to therapiesYun Chen, David M Holtzman
Cold Spring Harbor Perspectives in Medicine|May 4, 2012
The clinical problem of symptomatic Alzheimer disease and mild cognitive impairmentRawan Tarawneh, David M Holtzman
CNS & Neurological Disorders Drug Targets|April 10, 2009
Critical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and interventionRawan Tarawneh, David M Holtzman
Biomarkers in Medicine|April 14, 2010
Biomarkers will revolutionize the way we diagnose and treat Alzheimer's diseaseAlison Goate, David M Holtzman
Advances in Experimental Medicine and Biology|February 26, 2020
Amyloid-β and Tau at the Crossroads of Alzheimer's DiseaseGilbert Gallardo, David M Holtzman
Seminars in Immunology|March 2, 2022
APOE mediated neuroinflammation and neurodegeneration in Alzheimer's diseaseSamira Parhizkar, David M Holtzman
Molecular Neurodegeneration|April 4, 2023
Insights from new in vivo models of TREM2 variantsNimansha Jain, David M Holtzman
Neuron|March 7, 2025
The night's watch: Exploring how sleep protects against neurodegenerationSamira Parhizkar, David M Holtzman
Pageof 61

Showing results (21-30 of 602) with videos related to

Sort By:
Pageof 61
Neuropharmacology|April 17, 2010
Biomarkers in translational research of Alzheimer's diseaseRawan Tarawneh, David M Holtzman
Nature Reviews. Immunology|August 25, 2018
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlightYang Shi, David M Holtzman
Trends in Immunology|September 15, 2024
New insights into innate immunity in Alzheimer's disease: from APOE protective variants to therapiesYun Chen, David M Holtzman
Cold Spring Harbor Perspectives in Medicine|May 4, 2012
The clinical problem of symptomatic Alzheimer disease and mild cognitive impairmentRawan Tarawneh, David M Holtzman
CNS & Neurological Disorders Drug Targets|April 10, 2009
Critical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and interventionRawan Tarawneh, David M Holtzman
Biomarkers in Medicine|April 14, 2010
Biomarkers will revolutionize the way we diagnose and treat Alzheimer's diseaseAlison Goate, David M Holtzman
Advances in Experimental Medicine and Biology|February 26, 2020
Amyloid-β and Tau at the Crossroads of Alzheimer's DiseaseGilbert Gallardo, David M Holtzman
Seminars in Immunology|March 2, 2022
APOE mediated neuroinflammation and neurodegeneration in Alzheimer's diseaseSamira Parhizkar, David M Holtzman
Molecular Neurodegeneration|April 4, 2023
Insights from new in vivo models of TREM2 variantsNimansha Jain, David M Holtzman
Neuron|March 7, 2025
The night's watch: Exploring how sleep protects against neurodegenerationSamira Parhizkar, David M Holtzman
Pageof 61